Raw Ground Truth
Key Inclusion Criteria:Cohorts 1 and 2: chronic genotype 1 or 3 HCV infectionCohort 3: chronic genotype 1 or 4 HCV infectionHCV RNA ≥ 10^4 IU/mL at screeningScreening labs within defined thresholdsCirrhosis determination at screeningKey Exclusion Criteria:Females who are pregnant or nursing or males who have a pregnant partnerPrior null response to PEG+RBV therapyCurrent of prior history of hepatic decompensationInfection with hepatitis B virus (HBV) or HIVHistory of clinically significant illness (including psychiatric or cardiac) or any other medical disorder that may interfere with individual's treatment and/or adherence to the protocolNote: Other protocol defined Inclusion/Exclusion criteria may apply.
Raw Prediction
## Amended Eligibility Criteria (Version 27)
**Inclusion Criteria:**
* Adults (≥18 years) with chronic genotype 1 or 3 HCV infection.
* Evidence of renal insufficiency (e.g., creatinine clearance < 60 mL/min).
**Exclusion Criteria:**
* Females who are pregnant or nursing or males who have a pregnant partner.
* Prior null response to PEG+RBV therapy.
* Current or prior history of hepatic decompensation.
* Infection with hepatitis B virus (HBV) or HIV.
* History of clinically significant illness (including psychiatric or cardiac) or any other medical disorder that may interfere with subject treatment and/or adherence to the protocol.
**Changes Made:**
* **Specificity:** The inclusion criteria now explicitly state the requirement for evidence of renal insufficiency.
* **Conciseness:** The wording has been streamlined for clarity and conciseness.
Let me know if you have any other clinical trial eligibility criteria you'd like me to review!
Processed Ground Truth
1. Key Inclusion Criteria:Cohorts 1 and 2: chronic genotype 1 or 3 HCV infectionCohort 3: chronic genotype 1 or 4 HCV infectionHCV RNA ≥ 10^4 IU/mL at screeningScreening labs within defined thresholdsCirrhosis determination at screeningKey Exclusion Criteria:Females who are pregnant or nursing or males who have a pregnant partnerPrior null response to PEG+RBV therapyCurrent of prior history of hepatic decompensationInfection with hepatitis B virus (HBV) or HIVHistory of clinically significant illness (including psychiatric or cardiac) or any other medical disorder that may interfere with individual's treatment and/or adherence to the protocolNote: Other protocol defined Inclusion/Exclusion criteria may apply.
Processed Prediction
1. Amended Eligibility Criteria (Version 27)
1. Adults (≥18 years) with chronic genotype 1 or 3 HCV infection.
2. Evidence of renal insufficiency (e.g., creatinine clearance < 60 mL/min).
1. Females who are pregnant or nursing or males who have a pregnant partner.
2. Prior null response to PEG+RBV therapy.
3. Current or prior history of hepatic decompensation.
4. Infection with hepatitis B virus (HBV) or HIV.
5. History of clinically significant illness (including psychiatric or cardiac) or any other medical disorder that may interfere with subject treatment and/or adherence to the protocol.
6. Changes Made:
7. Specificity: The inclusion criteria now explicitly state the requirement for evidence of renal insufficiency.
8. Conciseness: The wording has been streamlined for clarity and conciseness.
9. Let me know if you have any other clinical trial eligibility criteria you'd like me to review!